Walleye Capital LLC Has $5.90 Million Holdings in Alphatec Holdings, Inc. (NASDAQ:ATEC)

Walleye Capital LLC boosted its stake in Alphatec Holdings, Inc. (NASDAQ:ATEC) by 3.2% during the 3rd quarter, Holdings Channel.com reports. The institutional investor owned 1,061,462 shares of the medical technology company’s stock after buying an additional 32,529 shares during the period. Walleye Capital LLC’s holdings in Alphatec were worth $5,902,000 at the end of the most recent reporting period.

A number of other large investors have also recently bought and sold shares of ATEC. Vanguard Group Inc. grew its stake in Alphatec by 1.2% during the first quarter. Vanguard Group Inc. now owns 5,458,847 shares of the medical technology company’s stock worth $75,278,000 after buying an additional 64,648 shares during the last quarter. Price T Rowe Associates Inc. MD boosted its holdings in shares of Alphatec by 14.2% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 26,346 shares of the medical technology company’s stock worth $364,000 after acquiring an additional 3,268 shares in the last quarter. Comerica Bank grew its position in Alphatec by 64.8% during the 1st quarter. Comerica Bank now owns 6,443 shares of the medical technology company’s stock worth $89,000 after acquiring an additional 2,534 shares during the last quarter. Cetera Advisors LLC increased its holdings in Alphatec by 15.6% during the 1st quarter. Cetera Advisors LLC now owns 12,720 shares of the medical technology company’s stock valued at $175,000 after purchasing an additional 1,720 shares in the last quarter. Finally, SG Americas Securities LLC raised its position in Alphatec by 44.6% in the 2nd quarter. SG Americas Securities LLC now owns 14,495 shares of the medical technology company’s stock valued at $151,000 after purchasing an additional 4,472 shares during the last quarter. 66.35% of the stock is currently owned by institutional investors.

Alphatec Price Performance

ATEC opened at $10.48 on Monday. The company has a fifty day moving average price of $7.11 and a two-hundred day moving average price of $8.18. The firm has a market capitalization of $1.49 billion, a PE ratio of -8.19 and a beta of 1.31. Alphatec Holdings, Inc. has a 52 week low of $4.88 and a 52 week high of $17.34. The company has a debt-to-equity ratio of 30.21, a quick ratio of 1.15 and a current ratio of 2.32.

Wall Street Analyst Weigh In

ATEC has been the subject of a number of research reports. Lake Street Capital lowered their target price on Alphatec from $32.00 to $18.00 and set a “buy” rating for the company in a research note on Tuesday, September 3rd. HC Wainwright reaffirmed a “buy” rating and issued a $20.00 target price on shares of Alphatec in a research note on Thursday, October 31st. Needham & Company LLC reiterated a “buy” rating and set a $13.00 target price on shares of Alphatec in a research report on Thursday, October 31st. Barclays raised their price target on shares of Alphatec from $19.00 to $20.00 and gave the company an “overweight” rating in a report on Tuesday, November 19th. Finally, Canaccord Genuity Group reiterated a “buy” rating and issued a $20.00 price objective on shares of Alphatec in a research report on Friday, August 30th. One equities research analyst has rated the stock with a hold rating and eight have assigned a buy rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $17.11.

Alphatec Profile

Alphatec Holdings, Inc, a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders in the United States and internationally. It manufactures and sells implants and instruments through third-party suppliers. The company offers Alpha InformatiX product platform, including EOS imaging system that provides full-body imaging; VEA alignment mobile application, which leverages EOS technology to more quickly quantify alignment parameters on a mobile device; SafeOp Neural InformatiX System that automates electromyographic and somatosensory evoked potential monitoring; and Valence, an intra-operative system that integrates navigation and robotics into spine procedures, as well as Sigma Prone TransPsoas (PTP) Access and PTP Patient Positioning Systems.